OneWorld Health awarded Sapling Foundation grant
Nonprofit pharmaceutical to engage industry in global health partnerships
San Francisco, Calif. – May 3, 2005 – The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the U.S., today announced it received a grant from the Sapling Foundation (Woodside, Calif.) to further engage the pharmaceutical industry in global health partnerships to benefit developing countries. This is the second such grant from the Foundation in support of fostering collaborations with executive and scientific talent from industry.
"This generous grant from the Sapling Foundation will allow OneWorld Health to continue engaging the expertise of senior pharmaceutical executives who have already stepped forward and to begin a dialogue with those who may not be aware of this opportunity," stated founder and CEO Victoria Hale, Ph.D. "OneWorld Health has already benefited from the generosity of people involved with the pharmaceutical industry through donations of time, resources, expertise and drug leads. We look forward to more collaborations as a means to fulfill our goal of bringing forth new medicines for people in the developing world."
Among the world's poorest people, six in 10 die of infectious diseases. For example, diarrhea kills two million children each year. Malaria still infects at least 500 million people each year. And visceral leishmaniasis, a fatal disease that is transmitted by sand flies, infects an estimated 1.5 million people worldwide.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.